Orally administered penicillamine is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein-carotid artery interposition grafts

Journal of Thoracic and Cardiovascular Surgery

Volumn 133, Issue 2, 2007, Pages 494-500

  Wan, Song ^a   Shukla, Nilima ^b   Yim, Anthony P C ^a   Johnson, Jason L ^b   Angelini, Gianni D ^b   Jeremy, Jamie Y ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CELL NUCLEUS ANTIGEN; COPPER; PENICILLAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY SURGERY; ARTICLE; CAROTID ARTERY; CELL DIVISION; CELL PROLIFERATION; COPPER BLOOD LEVEL; DRUG EFFECT; DRUG INHIBITION; GRAFT FAILURE; HUMAN; HUMAN CELL; IN VITRO STUDY; INTIMA; LANDRACE; MORPHOMETRICS; MUSCLE CELL; NONHUMAN; POTATO; PRIORITY JOURNAL; SAPHENOUS VEIN GRAFT; SWINE; TISSUE SECTION; VASCULAR SMOOTH MUSCLE;

ADMINISTRATION, ORAL; ANASTOMOSIS, SURGICAL; ANIMALS; BIOPSY, NEEDLE; CAROTID ARTERY, COMMON; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GRAFT OCCLUSION, VASCULAR; IMMUNOHISTOCHEMISTRY; MALE; PENICILLAMINE; PHOTOMICROGRAPHY; PROBABILITY; REFERENCE VALUES; SAPHENOUS VEIN; STATISTICS, NONPARAMETRIC; SWINE; TUNICA INTIMA;

EID: 33846357756     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2006.08.071     Document Type: Article

References (34)

1. Fitzgibbon G.M., Kafka H.P., Leach A.J., Keon W.J., Hooper G.D., and Burton J.R. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and re-operation in 1,388 patients during 25 years. J Am Coll Cardiol 28 (1999) 616-626
2. Favaloro R.G. Critical analysis of coronary artery bypass graft surgery: a 30-year journey. J Am Coll Cardiol 31 4 Suppl B (1998) 1B-63B
3. Mortwani J.G., and Topol E.J. Aortocoronary saphenous vein graft disease. Pathogenesis, predisposition and prevention. Circulation 97 (1998) 916-931
4. Davies M.G., and Hagen P.O. Pathobiology of intimal hyperplasia. Br J Surg 81 (1995) 1254-1269
5. Campeau L. Lipid lowering and coronary bypass graft surgery. Curr Opin Cardiol 15 (2000) 395-399
6. Jeremy J.Y., Shukla N., Angelini G.D., Wan I., Talpahewa S.P., and Ascione R. Sustained increases in homocysteine, copper and ceruloplasmin following coronary artery bypass grafting. Ann Thorac Surg 74 (2002) 1553-1557
7. Fox P.L., Mazumder B., and Ehrenwald E. Ceruloplasmin and cardiovascular disease. Free Radic Biol Med 28 (2000) 1735-1744
8. Shukla N., Maher J., Masters J., Angelini G.D., and Jeremy J.Y. Does oxidative stress change ceruloplasmin from a protective to a vasculopathic risk factor?. Atherosclerosis 187 (2006) 238-250
9. Mandinov L., Mandinova A., Kyurkchiev S., Kyurkchiev D., Kehayov I., Kolev V., et al. Copper chelation represses the vascular response to injury. Proc Natl Acad Sci U S A 100 (2003) 6700-6705
10. Volker W., Dorszewski A., Unruh V., Robenek H., Bretihardt G., and Buddecke E. Copper-induced inflammatory reactions of rat carotid arteries mimic restenosis/arteriosclerosis-like neointima formation. Atherosclerosis 130 (1997) 29-36
11. Clements P.J., Seibold J.R., Furst D.E., Mayes M., White B., Wigley F., et al. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial: lessons learned. Semin Arthritis Rheum 33 (2004) 249-263
12. Martins da Costa C., Baldwin D., Portmann B., Lolin Y., Mowat A.P., and Mieli-Vergani G. Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson's disease. Hepatology 15 (1992) 609-615
13. Ogihara H., Ogihara T., Miki M., Yasuda H., and Mino M. Plasma copper and antioxidant status in Wilson's disease. Pediatr Res 37 (1995) 219-226
14. Wan S., Yim A., Bulbulia R.A., Johnson J.L., Smith F.C., Angelini G.D., et al. The endothelin 1A receptor antagonist BSF 302146 is a potent inhibitor of porcine vein graft thickening in vivo. J Thorac Cardiovasc Surg 127 (2004) 1317-1322
15. Shukla N., Rowe D., Hinton J., Angelini G.D., and Jeremy J.Y. Calcium and the replication of human vascular smooth muscle cells: studies on the translocation of extracellular signal regulated kinase (ERK and cyclin D1 expression). Eur J Pharmacol 509 (2005) 21-30
16. Freshney R.I. Culture of animal cells: a manual of basic techniques. 3rd ed (1993), John Wiley & Sons, New York p. 48
17. Mandinov L., Moodie K.L., Mandinova A., Zhuang Z., Redican F., Baklanova D., et al. Inhibition of in-stent restenosis by oral copper chelation in porcine coronary arteries. Am J Physiol Heart Circ Physiol 29 (2006) H2692-H2697
18. Moon S.K., Jung S.Y., Choi Y.H., Lee Y.C., Patterson C., and Kim C.H. PDTC, metal chelating compound, induces G1 phase cell cycle arrest in vascular smooth muscle cells through inducing p21Cip1 expression: involvement of p38 mitogen activated protein kinase. Cell Physiol 198 (2004) 310-323
19. Pan Q., Bao L.W., and Merajver S.D. Tetrathiomolybdate inhibits angiogenesis and metastasis through suppression of the NFκB signaling cascade. Mol Cancer Res 1 (2003) 701-706
20. Popilis V.A., Cornelissen I., Sandoval-Copper M.J., Weeks L., Noria F.A., and Castellino F.J. Remodeling of the vessel wall after copper-induced injury is highly attenuated in mice with a total deficiency of plasminogen activator inhibitor-1. Am J Pathol 158 (2001) 107-117
21. Rucker R.B., Kosonen T., Clegg M.S., Mitchell A.E., Rucker B.R., Uriu-Hare J.Y., et al. Copper, lysyl oxidase, and extracellular matrix protein cross-linking. Am J Clin Nutr 67 5 Suppl (1998) 996S-1002S
22. Newby A.C. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 85 (2005) 1-31
23. Field L.S., Luk E., and Culotta V.C. Copper chaperones: personal escorts for metal ions. J Bioenerg Biomembr 34 (2002) 373-379
24. Choi S.Y., Kwon H.Y., Kwon O.B., Eum W.S., and Kang J.H. Fragmentation of human ceruloplasmin induced by hydrogen peroxide. Biochimie 82 (2000) 175-180
25. Musci G., Fraterrigo T.Z., Calabrese L., and McMillin D.R. On the lability and functional significance of the type I copper pool in ceruloplasmin. J Biol Inorg Chem 4 (1999) 441-446
26. Kang J.H., Kim K.S., Choi S.Y., Kwon H.Y., and Won M.H. Oxidative modification of human ceruloplasmin by peroxyl radicals. Biochim Biophys Acta 1568 (2001) 30-36
27. Jeremy J.Y., Shukla N., Muzaffar S., and Angelin G.D. Reactive oxygen species, vascular disease and cardiovascular surgery. Curr Vasc Pharmacol 2 (2004) 229-236
28. Jeremy J.Y., Yim A.P., Wan S., and Angelini G.D. Oxidative stress, nitric oxide and vascular disease. Cardiovasc Surg 17 (2002) 324-327
29. Shukla N., Koupparis A., Jones R.A., Persad R., Angelini G.D., and Jeremy J.Y. Penicillamine administration reverses the inhibitory effect of hyperhomocysteinaemia on endothelium-dependent relaxation and superoxide formation in the aorta of the rabbit. Eur J Pharmacol 531 (2006) 201-208
30. Iwama Y., Mokuno H., Yokoi H., Daida H., Yamaguchi H., and Hosoda Y. [Elevated levels of plasma homocysteine related to saphenous vein graft disease after coronary artery bypass graft surgery.] Japanese. J Cardiol 32 (1998) 357-362
31. Irvine C., Wilson Y.G., Currie I.C., McGrath C., Scott J., Day A., et al. Hyperhomocysteinaemia is a risk factor for vein graft stenosis. Eur J Vasc Endovasc Surg 12 (1996) 304-309
32. Burkitt J. A critical overview of the chemistry of copper-dependent low density lipoprotein oxidation: roles of lipid hydroperoxides, alpha-tocopherol, thiols, and ceruloplasmin. Arch Biochem Biophys 394 (2001) 117-135
33. Hultberg B., Andersson A., and Isaksson A. The cell-damaging effects of low amounts of homocysteine and copper ions in human cell line cultures are caused by oxidative stress. Toxicology 21 (1997) 33-40
34. Brewer G.J. Tetrathiomolybdate anticopper therapy for Wilson's disease inhibits angiogenesis, fibrosis and inflammation. J Cell Mol Med 7 (2003) 11-20